Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-18-002049
Filing Date
2018-03-16
Accepted
2018-03-16 16:33:26
Documents
1
Period of Report
2018-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SHERRINGTON formfoursherrington.html 4  
1 FORM 4 SHERRINGTON formfoursherrington.xml 4 7646
  Complete submission text file 0001171843-18-002049.txt   9024
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY A1 V5G4W8
Business Address
ROBIN SHERRINGTON (Reporting) CIK: 0001619962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 18696051